Validation and development of a modified breast graded prognostic assessment as a tool for survival in patients with breast cancer and brain metastases

Journal of Clinical Oncology

Volumn 33, Issue 20, 2015, Pages 2239-2245

  Subbiah, Ishwaria M ^a   Lei, Xiudong ^a   Weinberg, Jeffrey S ^a   Sulman, Erik P ^a   Chavez Macgregor, Mariana ^a   Tripathy, Debu ^a   Gupta, Rohan ^a   Varma, Ankur ^a   Chouhan, Jay ^a   Guevarra, Richard P ^a   Valero, Vicente ^a   Gilbert, Mark R ^a   Gonzalez Angulo, Ana M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BRAIN METASTASIS; BREAST CANCER; BREAST GRADED PROGNOSTIC ASSESSMENT; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VALIDATION STUDY; AGE; BRAIN NEOPLASMS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CANCER GRADING; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; FACTUAL DATABASE; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SECONDARY;

AGE FACTORS; BRAIN NEOPLASMS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84941334997     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.8517     Document Type: Article

References (33)

1. Pestalozzi BC: Brain metastases and subtypes of breast cancer. Ann Oncol 20:803-805, 2009.
2. Nabors LB, Ammirati M, Bierman PJ, et al: Central nervous system cancers. J Natl Compr Canc Netw 11:1114-1151, 2013.
3. Dawood S, Broglio K, Esteva FJ, et al: Survival among women with triple receptor-negative breast cancer and brain metastases. Ann Oncol 20:621- 627, 2009.
4. Kennecke H, Yerushalmi R, Woods R, et al: Metastatic behavior of breast cancer subtypes. J Clin Oncol 28:3271-3277, 2010.
5. Tham YL, Sexton K, Kramer R, et al: Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 107:696-704, 2006.
6. Pestalozzi BC, Zahrieh D, Price KN, et al: Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 17:935-944, 2006.
7. Hofer S, Pestalozzi BC: Treatment of breast cancer brain metastases. Eur J Pharmacol 717:84- 87, 2013.
8. Schouten LJ, Rutten J, Huveneers HA, et al: Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698- 2705, 2002.
9. Lin NU, Bellon JR, Winer EP: CNS metastases in breast cancer. J Clin Oncol 22:3608-3617, 2004.
10. Swain SM, Baselga J, Miles D, et al: Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: Results from the randomized phase III study CLEOPATRA. Ann Oncol 25:1116-1121, 2014.
11. Balduzzi S, Mantarro S, Guarneri V, et al: Trastuzumab-containing regimens for metastatic breast cancer. Cochrane Database Syst Rev 6:CD006242, 2014.
12. Arslan UY, Oksuzoglu B, Aksoy S, et al: Breast cancer subtypes and outcomes of central nervous system metastases. Breast 20:562-567, 2011.
13. Harrell JC, Prat A, Parker JS, et al: Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat 132:523-535, 2012.
14. Anders CK, Deal AM, Miller CR, et al: The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 117:1602-1611, 2011.
15. Le Scodan R, Massard C, Jouanneau L, et al: Brain metastases from breast cancer: Proposition of new prognostic score including molecular subtypes and treatment. J Neurooncol 106:169-176, 2012.
16. Le Scodan R, Massard C, Mouret-Fourme E, et al: Brain metastases from breast carcinoma: Validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score. Int J Radiat Oncol Biol Phys 69:839-845, 2007.
17. Sperduto PW, Kased N, Roberge D, et al: Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 82:2111-2117, 2012.
18. Nieder C, Marienhagen K, Astner ST, et al: Prognostic scores in brain metastases from breast cancer. BMC Cancer 9:105, 2009.
19. Barnholtz-Sloan JS, Yu C, Sloan AE, et al: A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol 14:910-918, 2012.
20. Sperduto PW, Kased N, Roberge D, et al: Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419-425, 2012.
21. Sperduto PW, Chao ST, Sneed PK, et al: Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4, 259 patients. Int J Radiat Oncol Biol Phys 77:655-661, 2010.
22. Sperduto PW, Berkey B, Gaspar LE, et al: A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1, 960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510-514, 2008.
23. Niwinska A, Murawska M: New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 82:2065-2071, 2012.
24. Therneau TM, Atkinson EJ: An Introduction to Recursive Partitioning Using the RPART Routines. Mayo Foundation, February 11, 2000. http://www.mayo.edu/research/documents/rpartminipdf/doc-10027257.
25. Harrell FE: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer, 2001.
26. Lederman G, Wronski M, Fine M: Fractionated radiosurgery for brain metastases in 43 patients with breast carcinoma. Breast Cancer Res Treat 65:145-154, 2001.
27. Eichler AF, Kuter I, Ryan P, et al: Survival in patients with brain metastases from breast cancer: The importance of HER-2 status. Cancer 112:2359- 2367, 2008.
28. Firlik KS, Kondziolka D, Flickinger JC, et al: Stereotactic radiosurgery for brain metastases from breast cancer. Ann Surg Oncol 7:333-338, 2000.
29. Matsunaga S, Shuto T, Kawahara N, et al: Gamma knife surgery for metastatic brain tumors from primary breast cancer: Treatment indication based on number of tumors and breast cancer phenotype. J Neurosurg 113:65-72, 2010 (suppl).
30. Lentzsch S, Reichardt P, Weber F, et al: Brain metastases in breast cancer: Prognostic factors and management. Eur J Cancer 35:580-585, 1999.
31. Melisko ME, Moore DH, Sneed PK, et al: Brain metastases in breast cancer: Clinical and pathologic characteristics associated with improvements in survival. J Neurooncol 88:359-365, 2008.
32. Graesslin O, Abdulkarim BS, Coutant C, et al: Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol 28:2032-2037, 2010.
33. Gaspar LE, Scott C, Murray K, et al: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:1001-1006, 2000.